rituximab,ibrutinib,Bendamustine
biogen,roche,janssen,abbvie,teva pharmaceuticals,novartis
['lymsm', 'lba7502', 'rituximab', 'shine']
 happening now:
lba7502: primary results from the phase iii #shine study of ibrutinib + bendamustine-rituximab (br) and r maintenance as a 1l treatment for older patients with mcl #lymsm e450 oral abstract session
#asco22
@UconnIM | HemOnc @AUBMC_Official | @USEKofficial Alumni | @ASCO SM Editor @JCOGO_ASCO | VTP Award @ASH_Hematology | Views are my own FCOI: https://t.co/nLxBFc8CcY